Study types
- article 4
Condition tags
- endometriosis 1
Top journals
Frequent coauthors
- Zhijian Xiao 3
- Yudi Zhang 3
- Zefeng Xu 3
- Lijuan Pan 3
- Shiqiang Qu 3
- Tiejun Qin 3
- Peihong Zhang 2
- Liwei Fang 2
- Hongli Zhang 2
- Naibo Hu 2
2024
article
2022
Ruxolitinib is a safe and effective therapy of myeloproliferative neoplasm-associated (MPN) myelofibrosis. However, often there are dose reductions and/or therapy interruptions because of therapy-related adverse events (AEs), especially ane…
article
2018
Abstract Low-dose thalidomide and prednisone alone or combined are effective therapies in some persons with primary myelofibrosis (PMF) and anemia with or with RBC transfusion dependence. Danazol is also effective in some persons with PMF a…
article
2014
OBJECTIVE: To observe the clinical effects of low-dose thalidomide (THAL) and prednisone (PRED) with or without danazol (DANA) in patients with primary myelofibrosis (PMF) associated anemia. METHODS: A cohort of 58 PMF patients with anemia …
article
2012
OBJECTIVE: To identify the differential expressed proteins, and to investigate the relationship between altered expression of annexin A4 during window of implantation [WOI (at day-6 after ovulatory day)] in infertile patients with endometri…